Providing evidence to inform policy: Pioneering the use of DOT for STH chemotherapy amongst expectant mothers attending antenatal clinics in rural coastal Kenya
Research question
1. What is the positivity rate of STH among pregnant mothers attending the ANC?
2. What is the difference in the STH burden in women who receive DOT and those who receive standard of care?
3. How acceptable is the DOT strategy in administering mebendazole among health care providers?
4. What is the information gap on STH preventive measures experienced by expectant mothers attending ANC clinics in Kilifi county?
Study sites
Chasimba rural health facility, Kenya
In progress
Notes
Grant awardee: Rodgers Onsomu Moindi